BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33881050)

  • 1. Supramolecular nanomedicine derived from cucurbit[7]uril-conjugated nano-graphene oxide for multi-modality cancer therapy.
    Ding YF; Kwong CHT; Li S; Pan YT; Wei J; Wang LH; Mok GSP; Wang R
    Biomater Sci; 2021 May; 9(10):3804-3813. PubMed ID: 33881050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
    Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
    Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-based supramolecular nanomedicine with optimized ratio of oxaliplatin/chlorin e6 for combined chemotherapy and O
    Ding YF; Xu X; Li J; Wang Z; Luo J; Mok GSP; Li S; Wang R
    Acta Biomater; 2023 Jul; 164():397-406. PubMed ID: 37004784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of an AIEgen functionalized cucurbit[7]uril for subcellular bioimaging and synergistic photodynamic therapy and supramolecular chemotherapy.
    Chen J; Li S; Wang Z; Pan Y; Wei J; Lu S; Zhang QW; Wang LH; Wang R
    Chem Sci; 2021 Apr; 12(22):7727-7734. PubMed ID: 34168825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the stability of cucurbit[8]uril-based ternary host-guest complexation in physiological environment and the fabrication of a supramolecular theranostic nanomedicine.
    Wu H; Chen Z; Qi S; Bai B; Ye J; Wu D; Shen J; Kang F; Yu G
    J Nanobiotechnology; 2021 Oct; 19(1):330. PubMed ID: 34670552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-Guest Interactions between Oxaliplatin and Cucurbit[7]uril/Cucurbit[7]uril Derivatives under Pseudo-Physiological Conditions.
    Wu H; Chen H; Tang B; Kang Y; Xu JF; Zhang X
    Langmuir; 2020 Feb; 36(5):1235-1240. PubMed ID: 31941282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cucurbit[8]uril Regulated Activatable Supramolecular Photosensitizer for Targeted Cancer Imaging and Photodynamic Therapy.
    Wang XQ; Lei Q; Zhu JY; Wang WJ; Cheng Q; Gao F; Sun YX; Zhang XZ
    ACS Appl Mater Interfaces; 2016 Sep; 8(35):22892-9. PubMed ID: 27513690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular Chemotherapy: Cooperative Enhancement of Antitumor Activity by Combining Controlled Release of Oxaliplatin and Consuming of Spermine by Cucurbit[7]uril.
    Chen Y; Huang Z; Zhao H; Xu JF; Sun Z; Zhang X
    ACS Appl Mater Interfaces; 2017 Mar; 9(10):8602-8608. PubMed ID: 28194936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecular Nanomedicine Constructed from Cucurbit[8]uril-Based Amphiphilic Brush Copolymer for Cancer Therapy.
    Wu D; Li Y; Yang J; Shen J; Zhou J; Hu Q; Yu G; Tang G; Chen X
    ACS Appl Mater Interfaces; 2017 Dec; 9(51):44392-44401. PubMed ID: 29205029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-mimicking supramolecular nanomedicine with precisely integrated prodrugs for cascade amplification of synergistic chemotherapy.
    Ding YF; Wang Z; Kwong CHT; Zhao Y; Mok GSP; Yu HZ; Wang R
    J Control Release; 2023 Aug; 360():82-92. PubMed ID: 37331605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSMA-Targeted Supramolecular Nanoparticles Prepared From Cucurbit[8]uril-Based Ternary Host-Guest Recognition for Prostate Cancer Therapy.
    Zhang X; Qi S; Liu D; Du J; Jin J
    Front Chem; 2022; 10():847523. PubMed ID: 35223775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric Nanomedicine with "Lego" Surface Allowing Modular Functionalization and Drug Encapsulation.
    Sun C; Zhang H; Li S; Zhang X; Cheng Q; Ding Y; Wang LH; Wang R
    ACS Appl Mater Interfaces; 2018 Aug; 10(30):25090-25098. PubMed ID: 29993234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming barriers with non-covalent interactions: supramolecular recognition of adamantyl cucurbit[
    Alešković M; Šekutor M
    RSC Med Chem; 2024 Feb; 15(2):433-471. PubMed ID: 38389878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supramolecular Chemotherapy with Cucurbit[
    Shukla S; Sagar B; Sood AK; Gaur A; Batra S; Gulati S
    ACS Appl Bio Mater; 2023 Jun; 6(6):2089-2101. PubMed ID: 37224296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional Photosensitizer Grafted on Polyethylene Glycol and Polyethylenimine Dual-Functionalized Nanographene Oxide for Cancer-Targeted Near-Infrared Imaging and Synergistic Phototherapy.
    Luo S; Yang Z; Tan X; Wang Y; Zeng Y; Wang Y; Li C; Li R; Shi C
    ACS Appl Mater Interfaces; 2016 Jul; 8(27):17176-86. PubMed ID: 27320692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide.
    Tian B; Wang C; Zhang S; Feng L; Liu Z
    ACS Nano; 2011 Sep; 5(9):7000-9. PubMed ID: 21815655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cucurbit[7]uril: an emerging candidate for pharmaceutical excipients.
    Kuok KI; Li S; Wyman IW; Wang R
    Ann N Y Acad Sci; 2017 Jun; 1398(1):108-119. PubMed ID: 28692768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemical Quantitation of Supramolecular Excipient@Drug Complexation: A General Assay Strategy Based on Competitive Host Binding with Surface-Immobilized Redox Guest.
    Qi L; Wang R; Yu HZ
    Anal Chem; 2020 Jan; 92(2):2168-2175. PubMed ID: 31858784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Assembled Oxaliplatin(IV) Prodrug-Porphyrin Conjugate for Combinational Photodynamic Therapy and Chemotherapy.
    Lim WQ; Yang G; Phua SZF; Chen H; Zhao Y
    ACS Appl Mater Interfaces; 2019 May; 11(18):16391-16401. PubMed ID: 31002492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cucurbit[8]uril-based supramolecular theranostics.
    Wu D; Wang J; Du X; Cao Y; Ping K; Liu D
    J Nanobiotechnology; 2024 May; 22(1):235. PubMed ID: 38725031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.